Journal
DRUG DISCOVERY TODAY
Volume 26, Issue 7, Pages 1574-1590Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2021.03.010
Keywords
-
Categories
Funding
- European Union Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie Grant [840964]
- Marie Curie Actions (MSCA) [840964] Funding Source: Marie Curie Actions (MSCA)
Ask authors/readers for more resources
Bioinks are crucial for the fabrication of artificial living-tissue constructs using 3D bioprinting technologies, with a significant application in cancer management. The ability to recreate tumor microenvironments using 3D bioprinting is a promising approach for drug development and in vitro cancer modeling.
'Bioinks' are important tools for the fabrication of artificial living-tissue constructs that are able to mimic all properties of native tissues via 3D bioprinting technologies. Bioinks are most commonly made by incorporating live cells of interest within a natural or synthetic biocompatible polymeric matrix. In oncology research, the ability to recreate a tumor microenvironment (TME) using by 3D bioprinting constitutes a promising approach for drug development, screening, and in vitro cancer modeling. Here, we review the different types of bioink used for 3D bioprinting, with a focus on its application in cancer management. In addition, we consider the fabrication of bioink using customized materials/cells and their properties in the field of cancer drug discovery.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available